Acadia Pharmaceuticals Stock Trading Halted Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- Atlassian results seen as 'game changer' for AI kills software worries
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Goldman Sachs on Acadia Pharmaceuticals (ACAD): 'We expect the stock to move lower on Tuesday given the results of the vote'
June 21, 2022 10:18 AM EDTGoldman Sachs analyst Salveen Richter reiterated a Neutral rating and $20.00 price target on Acadia Pharmaceuticals (NASDAQ: ACAD)
The analyst comments "The FDA's Psychopharmacologic Drugs Advisory Committee (PDAC) voted against pimavanserin (Nuplazid) as an effective treatment for hallucinations and delusions in Alzheimer's disease psychosis (ADP) (Vote: 9 No/3 Yes), and recommended... More
Acadia Pharma (ACAD) Resume Trading, Down 32%
June 21, 2022 7:11 AM EDTAcadia Pharma (NASDAQ: ACAD) Resume Trading, Down 32%
... More